CLMI CellMetrix, Inc. featured news, full reports, and detailed charts
CellMetrix, Inc. (CLMI/CLMI.PK) Wrap Up:
CellMetrix, Inc. operates as medical technology company that develops clinical testing applications and automated laboratory systems that together allow for the early detection, diagnosis, characterization, treatment, and monitoring of significant human diseases. The company currently is focused on developing clinical testing applications for lung cancer and has already fully developed and begun marketing its first clinical application called LungCheck to targeted healthcare providers.3 Employees
CellMetrix, Inc. (CLMI:OTC)
|
Market Cap
23.0K
|
Total Revenue
51.0K
|
|
|
EBITDA
3.8M
|
DILUTED EPS TTM
-0.59
|
|
|
P/E
--
|
P/S
0.4x
|
|
|
Return On Asset
--
|
Return On Equity
--
|
|
| K = Thousands M = Millions B = Billions | ||
CLMI Top Compensated Officers
No compensation data is available at this time for the top officers at this company.
Executives, Board Directors
CLMI Competitors
| Company | Last | Change | |
| No competitor information is available for CLMI. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | CLMI | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.4x |
|
| Price/Book | 0.0x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
|
CLMI |
||
CLMI transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent News About CellMetrix, Inc.
Would you like to leave a comment about CellMetrix, Inc. CLMI/CLMI.PK
Find out what social network information about CellMetrix, Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides CellMetrix, Inc. there is more great information available at Realpennies.com